NCT06060210View on ClinicalTrials.gov

Impact of Ketamine on Depressive Symptoms in Patients Undergoing Lumbo-peritoneal Shunt Insertion

PHASE4CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

September 29, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

December 1, 2024

Conditions

Depression, Anxiety

Interventions

DRUG

normal Saline

50-ml Saline

DRUG

Ketamine

50-ml volumes, and the ketamine concentration is 1 mg/ml

Trial Locations (1)

13511

Banha faculity of medicine, Banhā

All Listed Sponsors

lead

Benha University

OTHER